SB-Metsita 50 mg+1000 mg (Tablet)

Unit Price: ৳ 22.00 (20's pack: ৳ 440.00)

Medicine Details

Indications

  • Improves glycemic control in adults with type 2 diabetes mellitus
  • Adjunct to diet and exercise
  • Not for type 1 diabetes or diabetic ketoacidosis
  • Not studied in patients with a history of pancreatitis

Pharmacology

  • Combines sitagliptin and metformin for glycemic control
  • Sitagliptin: DPP-4 inhibitor, slows incretin hormone inactivation
  • Metformin: decreases hepatic glucose production, increases peripheral glucose uptake

Dosage & Administration

  • Individualized dosage based on current regimen, effectiveness, and tolerability
  • Initial or maintenance therapy should be individualized
  • Starting dose varies based on current treatment
  • Film-coated tablet: generally given twice daily with meals
  • Extended-release tablet: administer once daily with a meal, gradually escalate the dose

Interaction

  • Cationic drugs: use with caution if eliminated by renal tubular secretion
  • Phenprocoumon: metformin may decrease anticoagulant effect
  • Levothyroxine: may reduce hypoglycemic effect of metformin

Contraindications

  • Renal disease or dysfunction
  • Metabolic acidosis, diabetic ketoacidosis
  • History of serious hypersensitivity reaction

Side Effects

  • Common adverse reactions: diarrhea, upper respiratory tract infection, headache

Pregnancy & Lactation

  • Pregnancy Category B
  • Use during pregnancy only if clearly needed
  • Exercise caution when administered to a nursing woman

Precautions & Warnings

  • Risk of lactic acidosis, regular monitoring recommended
  • Decrease in vitamin B12 levels with long-term metformin use
  • Postmarketing reports of acute renal failure, pancreatitis, and allergic reactions
  • Evaluate patients for evidence of ketoacidosis or lactic acidosis
  • Consider lower dose of insulin or insulin secretagogue when used in combination

Overdose Effects

  • Usual supportive measures for sitagliptin overdose
  • Metformin overdose: dialyzable; consider hemodialysis for removal

Therapeutic Class

  • Combination oral hypoglycemic preparations

Storage Conditions

  • Store below 25°C, away from light and out of reach of children

Related Brands